Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Anal Bioanal Chem ; 2024 Aug 17.
Artículo en Inglés | MEDLINE | ID: mdl-39153104

RESUMEN

The request for novel hyphenated instruments and techniques, capable of affording exhaustive information and results, is a focus continuously watched out. In this context, the present work aimed at the development of an integrated system combining gas chromatographic (GC) separation with mass spectrometry (MS) and (solid deposition) Fourier transform infrared spectroscopy (FTIR) detection. An external transfer line was designed in the lab for the parallel coupling of the two detectors, in such a way to obtain complementary analytical information consisting of an MS spectrum, an IR spectrum and linear retention indices (LRI), within a single analysis. The instrument performance was demonstrated for the analysis of a commercial mixture consisting of 139 hydrocarbons, comprising linear, branched, unsaturated and aromatic compounds. A 100-m poly(dimethylsiloxane) column was employed for the separation, and the outlet flow was split 95:5 between the IR and MS detectors using two uncoated capillaries. The IR spectra were acquired from solid deposits on a zinc selenide disc (-90 °C), over a spot (detector area) of about 0.1 mm2, in the range of 4000-700 cm-1 and at a resolution of 4 cm-1. Final identification of the separated compounds by a library search was achieved by excluding incorrect results, sequentially using a three-filter approach (85% similarity against reference MS and IR library spectra and ±10 LRI unit tolerance). Based on these preliminary results, the GC-MS/sd-FTIR system is a promising tool for the characterization of complex matrix constituents, for which identification is cumbersome, by using only one detection technique.

2.
J Chromatogr A ; 1732: 465208, 2024 Sep 13.
Artículo en Inglés | MEDLINE | ID: mdl-39088897

RESUMEN

Piper gaudichaudianum Kunth essential oil (EO) is a natural source of bioactive components, having multiple therapeutic applications. Its chemical composition is highly variable, and strictly depends on abiotic factors, resulting in various biological activities. The present study details the utilization of multiple gas chromatographic techniques alongside nuclear magnetic resonance (NMR) spectroscopy to characterize the essential oil of Piper gaudichaudianum Kunth from Brazil. Seventy-six components were identified using GC-MS analysis, while enantio­selective multidimensional gas chromatography elucidated the enantiomeric distribution of eight chiral components, for the first time in the literature. Following GC-MS analysis, an unidentified component, constituting approximately 27 % of the total oil, prompted an isolation step through preparative gas chromatography. Through the combined use of nuclear magnetic resonance, GC-Fourier transform infrared spectroscopy (FTIR), and mass spectrometry (MS), the unknown molecule was structurally identified as 4-[(3E)­dec-3-en-1-yl]phenol. Remarkably, it was identified as a known molecule, gibbilimbol B, and not previously listed in any MS database. Subsequently, the spectrum was included in a commercial library, specifically the FFNSC 4.0 MS database, for the first time.


Asunto(s)
Cromatografía de Gases y Espectrometría de Masas , Espectroscopía de Resonancia Magnética , Aceites Volátiles , Piper , Piper/química , Aceites Volátiles/química , Aceites Volátiles/análisis , Brasil , Cromatografía de Gases y Espectrometría de Masas/métodos , Espectroscopía Infrarroja por Transformada de Fourier/métodos , Aceites de Plantas/química , Cromatografía de Gases/métodos
3.
Anal Bioanal Chem ; 414(1): 703-712, 2022 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-34841479

RESUMEN

Hyphenated techniques combining chromatographic and spectroscopic methods are the gold standard to effectively handle the emerging challenges in the analysis of unknown chemical components in mixtures, and in this regard the coupling of liquid chromatography to Fourier transform infrared spectroscopy (LC-FTIR) is no exception. While earlier attempts to couple LC to IR spectroscopy relied almost entirely on offline techniques, clear motivations for implementing online LC-FTIR instrumentation emerged from the need for shorter analysis time, a higher degree of automation and sample throughput, better reproducibility, and reduced contamination. Most recent designs of LC-FTIR concepts have aimed to combine the advantages of both approaches by means of a solvent-elimination interface. The hyphenated instrumentation and method presented in this research are based on a pneumatically assisted LC-FTIR interface, relying on a small-scale self-regulating spray dryer to attain desolvation of the LC eluent stream while retaining the spatial and temporal resolution of the dissolved substrates. Focused deposition of the dried analytes occurs onto a ZnSe disc for continuous transmission mid-IR analysis at a resolution of 4 cm-1. The optimization of the LC-FTIR technique is discussed in terms of interface parameters, limits of detection, and limits of quantification for a pair of furanocoumarin isomers differing in the position (linear or angular type) of the furan ring fused to coumarin. Finally, confident discrimination between the two closely related molecules was attained by matching the experimental FTIR spectra in a dedicated library. The quality match factors obtained were higher than 99% for both molecules. The limit of identification (LOI) was determined experimentally as the minimum amount of substance yielding a library-searchable IR spectrum (affording a quality match factor higher than 90%). Specifically, LOI of 0.6 µg and 1.25 µg was determined for psoralen and angelicin, respectively.


Asunto(s)
Contaminación de Medicamentos , Cromatografía Liquida/métodos , Reproducibilidad de los Resultados , Solventes , Espectroscopía Infrarroja por Transformada de Fourier/métodos
4.
Cardiovasc Intervent Radiol ; 33(6): 1270-7, 2010 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-19967372

RESUMEN

The purpose of this study was to assess the efficacy of cementoplasty in the treatment of sacral multiple myelomas. We retrospectively reviewed the records of eight patients (four women and four men; age range 47-68 years; mean age 57.8) who underwent cementoplasty for painful osteolytic localization of multiple myeloma between April 2007 and May 2009. The patients had difficulty walking because of increasing pain. Six patients had persistent pain despite other cementoplasties for vertebral and femoral localization, whereas two patients referred at the time of diagnosis had only sacral lesions. The clinical indication for treatment was (1) a pain intensity score ≥5 on visual analogue scale (VAS) and (2) pain totally or partially refractory to analgesic treatment in patients with a life expectancy >3 months. Technical planning was based on computed tomography and/or magnetic resonance imaging. Six patients had previously undergone radiotherapy or chemotherapy and were receiving varying doses of analgesics, whereas sacroplasty represented the first treatment for two patients. Five patients had monolateral local involvement, and the other patients had massive involvement of the sacrum; Technical success was achieved in all cases. We had only one small and asymptomatic foraminal leak. All patients experienced improvement in symptoms after the procedure, as demonstrated by improved VAS scores and performance status (PS) and decreased analgesic dose constant during follow-up. In our experience, percutaneous stabilization can be used effectively and safely in patients with focal or extensive involvement of the sacrum by multiple myeloma.


Asunto(s)
Mieloma Múltiple/cirugía , Sacro/cirugía , Neoplasias de la Columna Vertebral/cirugía , Vertebroplastia/métodos , Anciano , Femenino , Humanos , Imagen por Resonancia Magnética , Masculino , Persona de Mediana Edad , Mieloma Múltiple/patología , Dimensión del Dolor , Radiografía Intervencional , Estudios Retrospectivos , Sacro/patología , Neoplasias de la Columna Vertebral/secundario , Tomografía Computarizada por Rayos X , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA